Used in pharmaceutical research as a key intermediate in the synthesis of kinase inhibitors, particularly for targeting protein kinases involved in inflammatory diseases and cancer. Its structure supports high binding affinity to enzyme active sites, making it valuable in developing selective inhibitors. Also explored in medicinal chemistry for optimizing drug candidates with improved metabolic stability and bioavailability due to the presence of trifluoromethyl and methoxy groups. Employed in structure-activity relationship (SAR) studies to enhance potency and reduce off-target effects in therapeutic agents.